DFTX position history
The shares of Definium Therapeutics (DFTX) that Duquesne Family Office LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 356,600 shares, $17M, 0.32% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|